Cannabis
Green Light Solutions Announces Ontario Product Listing
VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) — Green Light Solutions (“GLS” or “the Company”), an innovation firm committed to driving excellence in the Cannabis industry, is pleased to announce the launch of the LoFi brand in the Ontario market. The flagship product, LoFi CBD Oil 1500, will be available through Ontario Cannabis Stores (OCS) and licensed retailers later this year.
The OCS, serving Canada’s largest consumer market, is the world’s largest cannabis buyer, Ontario’s sole wholesaler of regulated cannabis products, and the province’s exclusive online retailer.
“As a new brand in the space, receiving a listing from the highly competitive OCS is a validation of our LoFi product strategy. Our early success in B.C further illustrates the potential for CBD forward products that are both high-quality and affordably priced,” said Walker Patton, Corporate Development at GLS. “We are delighted with the positive reception of our product from B.C. customers, and we are excited to launch this highly anticipated product through the OCS.”
The LoFi product line offers potent, CBD forward formulations using highly concentrated CBD and premium ingredients. LoFi CBD Oil 1500 is a full-spectrum CBD oil containing hemp-derived CBD extract, made in B.C., and sustainably sourced MCT oil. All LoFi products feature the inLite supply chain traceability technology, providing customers unparalleled visibility into ingredient source and batch-specific lab results.
Later this year, an expanded suite of LoFi CBD products, including a 50 ml format of CBD Oil, will also be available in the B.C. market. LoFi continues to explore future supply agreements with provincial wholesalers.
About LoFi
LoFi is a BC-based independent cannabis brand passionate about three simple things: quality, innovation, and value. We are committed to upholding the highest quality standards through our inclusive CBD products that are market competitive in potency and price.
About Green Light Solutions
Green Light Solutions (GLS) is an innovation firm committed to driving excellence in the Cannabis industry. GLS delivers value across multiple cannabis verticals through an agile, tech-forward business model, following Cannabis and Hemp specific strategies. The Company’s leadership team combines extensive experience in the cannabis industry with strong manufacturing and technology development expertise and a robust I.P. portfolio.
www.grnlight.ca
www.loficannabis.ca
https://www.instagram.com/lofi.cannabis/
For further information, please contact:
GLS Media Relations – [email protected]
Cannabis
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
Cannabis
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
Cannabis
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis2 weeks ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 weeks ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis2 weeks ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis7 days ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis6 days ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan5 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis2 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa